Immunohistochemical detection of p53 protein expression as a prognostic indicator in wilms tumor

Simone Treiger Sredni, Beatriz de Camargo, Luiz Fernando Lopes, Roberto Teixeira, Andrew Simpson

Research output: Contribution to journalArticlepeer-review

39 Scopus citations


Background. Mutations of the tumor suppressor gene p53 are commonly found in several kinds of human cancer. In some types of neoplasms, accumulation of p53 protein has been reported to correlate with more aggressive clinical behavior. The role of p53 expression in Wilms tumors (WT) is not clear yet, but most studies have confirmed its correlation with anaplasia and advanced stage disease. Procedure. Ninety-seven WT were evaluated for p53 expression by immunohistochemistry in formalin-fixed parafin-embedded tissue and correlated with outcome. Tumors were classified as p53-Negative (p53-N) when no positivity was observed or only few cells showed weak positivity (0/1 +) and p53-Positive (p53-P) when there was a diffuse and strong nuclear positivity (2+/3+). Results. p53-P was detected in 13 out of 97 tumors and was associated with disease relapse (39 vs. 17%; P = 0.06) but not with anaplasia. Among p53-N patients only 5% had metastatic disease compared with 31% of the p53-P sample. (P = 0.038). Overall survival was 94% for patients with p53-N vs. 85% for patients with p53-P at 1 year (P = 0.34). Conclusions. p53 expression in Wilms tumor detected by immunohistochemistry seems to be associated with advanced disease and relapse.

Original languageEnglish (US)
Pages (from-to)455-458
Number of pages4
JournalMedical and Pediatric Oncology
Issue number5
StatePublished - 2001


  • Anaplasia
  • Pathology
  • Prognosis
  • Wilms tumors
  • p53

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Immunohistochemical detection of p53 protein expression as a prognostic indicator in wilms tumor'. Together they form a unique fingerprint.

Cite this